` ATER (Aterian Inc) vs S&P 500 Comparison - Alpha Spread

ATER
vs
S&P 500

Over the past 12 months, ATER has underperformed S&P 500, delivering a return of -33% compared to the S&P 500's 25% growth.

Stocks Performance
ATER vs S&P 500

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ATER vs S&P 500

Loading
ATER
S&P 500
Difference

Performance By Year
ATER vs S&P 500

Loading
ATER
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Aterian Inc vs Peers

S&P 500
ATER
000333
600690
000651
SN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Aterian Inc
Glance View

Market Cap
22.2m USD
Industry
Consumer products

Aterian, Inc. is a technology enabled consumer products company. The company is headquartered in New York City, New York and currently employs 156 full-time employees. The company went IPO on 2019-06-12. The Company’s cloud-based platform, artificial intelligence marketplace ecommerce engine (AIMEE), leverages machine learning, natural language processing and data analytics to streamline the management of products across online marketplaces, including Amazon, Shopify and Walmart. Aterian has thousands of stock-keeping units (SKUs) across 12 owned and operated brands and sells products in multiple categories, including home and kitchen appliances, health and wellness, beauty and consumer electronics. The Company’s brands include hOmeLabs, Truweo, Vremi, Xtava, RIF6, Mueller Australia, Pursteam, Pohl and Schmitt, Spiralizer, Healing Solutions and Aussie Health Co brands. Truweo, is an electronic commerce brand in the health and personal wellness category.

ATER Intrinsic Value
17.76 USD
Undervaluation 86%
Intrinsic Value
Price
Back to Top